PLA2G7 and hyperlipidemia: LDL-Lp-PLA2 is increased in patients with primary hypercholesterolemia and combined hyperlipidemia and data from large Caucasian popu-lation studies have supported plasma Lp-PLA2 (pri-marily LDL-associated Lp-PLA2) as a cardiovascular risk marker, independent of and additive to traditional risk factors (Table 1)[64-65].